← Leaderboards
Richard K. Gordon
Geneva Foundation
$2,881,859
Attributed
$2,881,859
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $599.5K · FY2006–10$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,881,859 · 1
By mechanism
U01$2,881,859 · 1
Top collaborators
No co-investigators on record.
Most similar at Geneva Foundation
Same institution · by research overlap
- Madhusoodana P. Nambiar$2,380,533
Others in their field
Top investigators on “Cholinergic”
- James E. Gern · University Of Wisconsin-Madison$33,185,753
- William W. Busse · University Of Wisconsin Madison$21,970,006
- Paul A. Newhouse · University Of Vermont &St Agric College$19,554,160
- Lorna W Role · New York State Psychiatric Institute$17,248,803
- Marina R. Picciotto · Yale University$15,243,674
- Elliott Jay Mufson · Rush University Medical Center$15,195,098
Research focus
CholinergicAbdomenAcetylcholineAnimal ModelAnticonvulsantsAcetylcholinesteraseAstrocytesAcuteBaseBloodBlood - Brain Barrier AnatomyBlood CirculationAreaBrainCattleCaviaAtropineCellsChargeChemical AgentsChemical StructureChemical SynthesisChemical Warfare AgentsCholinesterase Reactivators
Grant awards (5)
Next Generation Oxime Therapeutic for Chemical Agent Inhibited CNS (Brain) ChEs$570,184
U01 · FY2010 · NS · contact PI
Next Generation Oxime Therapeutic for Chemical Agent Inhibited CNS (Brain) ChEs$569,179
U01 · FY2009 · NS · contact PI
Next Generation Oxime Therapeutic for Chemical Agent Inhibited CNS (Brain) ChEs$571,059
U01 · FY2008 · NS · contact PI
Next Generation Oxime Therapeutic for Chemical Agent Inhibited CNS (Brain) ChEs$571,967
U01 · FY2007 · NS · contact PI
Next Generation Oxime Therapeutic for Chemical Agent Inhibited CNS (Brain) ChEs$599,470
U01 · FY2006 · NS · contact PI